Cargando…

Correction: Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570221/ https://www.ncbi.nlm.nih.gov/pubmed/33067346 http://dx.doi.org/10.1136/openhrt-2020-001350corr1

Ejemplares similares

Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19
por: DiNicolantonio, James J, et al.
Publicado: (2020)

Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors
por: DiNicolantonio, James J, et al.
Publicado: (2021)

Correction: Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients
por: Camprubí, Daniel, et al.
Publicado: (2022)

Antiviral and anti-inflammatory properties of ivermectin and its potential use in Covid-19()
por: Portmann-Baracco, Arianna, et al.
Publicado: (2020)

Correction: Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching
por: Kerr, Lucy, et al.
Publicado: (2022)

Correction to: Flaws in advance directives that request withdrawing assisted feeding in late-stage dementia may cause premature or prolonged dying
por: Terman, Stanley A., et al.
Publicado: (2022)

Considerations on the article «antiviral and anti-inflammatory properties of ivermectin and its potential use in COVID-19»()
por: Hernández-Vásquez, Akram, et al.
Publicado: (2020)

Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19
por: Khan, Md. Saiful Islam, et al.
Publicado: (2020)

Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19
por: Khan, Md. Saiful Islam, et al.
Publicado: (2020)

Correction: Cruciani et al. Ivermectin for Prophylaxis and Treatment of COVID-19: A Systematic Review and Meta-Analysis. Diagnostics 2021, 11, 1645
por: Cruciani, Mario, et al.
Publicado: (2021)

Correction: Gla-rich protein function as an anti-inflammatory agent in monocytes/macrophages: Implications for calcification-related chronic inflammatory diseases
Publicado: (2018)

Correction: Control, Elimination, and Eradication of River Blindness: Scenarios, Timelines, and Ivermectin Treatment Needs in Africa
por: Kim, Young Eun, et al.
Publicado: (2015)

Correction to: Iron chelation may harm patients with COVID-19
por: Garrick, Michael D., et al.
Publicado: (2021)

Correction to: Quantitative evaluation of anti-resorptive agent-related osteonecrosis of the jaw using bone single photon emission computed tomography in clinical settings: relationship between clinical stage and imaging
por: Okui, Taro, et al.
Publicado: (2022)

Correction to: COVID‑19 and therapy with essential oils having antiviral, anti‑inflammatory, and immunomodulatory properties
por: Asif, Muhammad, et al.
Publicado: (2021)

Reply to “Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19”
por: Khan, Md. Saiful Islam, et al.
Publicado: (2021)

Ivermectin and COVID-19
por: Wiwanitkit, Viroj
Publicado: (2021)

Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19
por: Awad, Hoda, et al.
Publicado: (2022)

The Use of Ivermectin in the Treatment of COVID-19
por: Shukla, Ajay Kumar, et al.
Publicado: (2023)

Correction: Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania
por: Kroidl, Inge, et al.
Publicado: (2016)

Correction to “Retrospective analysis of anti-inflammatory therapies during the first wave of COVID-19 at a community hospital”
por: Iglesias, Jose I, et al.
Publicado: (2022)

Correction to: Anti-migraine agents from an immunological point of view
por: Assas, Mushref Bakri
Publicado: (2021)

Correction: The Transcriptional Response of Caenorhabditis elegans to Ivermectin Exposure Identifies Novel Genes Involved in the Response to Reduced Food Intake
por: Laing, Steven T., et al.
Publicado: (2012)

Inhaled route and anti-inflammatory action of ivermectin: Do they hold promise in fighting against COVID-19?
por: Mittal, Niti, et al.
Publicado: (2021)

Correction: Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin
por: Veloso, Artur, et al.
Publicado: (2013)

Correction: Characterisation of Mesothelioma-Initiating Cells and Their Susceptibility to Anti-Cancer Agents
por: Pasdar, Elham Alizadeh, et al.
Publicado: (2016)

Correction to: LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions
por: Desimmie, Belete Ayele, et al.
Publicado: (2020)

Correction: Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer
Publicado: (2021)

Correction to: Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19
por: Chouchana, Laurent, et al.
Publicado: (2021)

Correction: Anti-Angiogenic and Anti-Inflammatory Properties of Kahweol, a Coffee Diterpene
por: Cárdenas, Casimiro, et al.
Publicado: (2011)

A five-day course of ivermectin may reduce the duration of COVID-19 illness
por: Ahmed, Sabeena, et al.
Publicado: (2021)

Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible?
por: Shukla, Dr. Ajay Kumar, et al.
Publicado: (2021)

Correction: Interactions of L-3,5,3'-Triiodothyronine, Allopregnanolone, and Ivermectin with the GABA(A) Receptor: Evidence for Overlapping Intersubunit Binding Modes
por: Westergard, Thomas, et al.
Publicado: (2015)

Correction: A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication?
por: Jittamala, Podjanee, et al.
Publicado: (2023)

Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19
por: Moutsopoulos, Haralampos M
Publicado: (2020)

Non-steroidal anti-inflammatory agent use may not be associated with mortality of coronavirus disease 19
por: Park, Jungchan, et al.
Publicado: (2021)

Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit
por: Sun, Duxin
Publicado: (2020)

Correction: A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agent
Publicado: (2017)

A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness
por: Ahmed, Sabeena, et al.
Publicado: (2021)

Correction: Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5lnmqmiilr0u1tonn0v16ncuau